Saturday, 17 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Beijing Avistone Pharmaceuticals Raises RMB 1 Billion in Series B Funding to Accelerate Drug Development

April 17, 2025
CompanyDrug

Boan Biotech Secures FDA Orphan Drug Designations for Pancreatic Cancer Treatments

November 12, 2024
CompanyDeals

Eli Lilly Teams Up with Fauna Bio to Uncover New Anti-Obesity Drug Targets

October 29, 2024
CompanyDrug

Gilead’s Kite Receives FDA Nod to Add Overall Survival Data to Yescarta for Large B-Cell Lymphoma

October 29, 2024
CompanyDrug

FDA Prioritizes Roche’s Xolair for Food Allergy Indication Extension Ahead of Q1 Decision

October 29, 2024
CompanyDrug

Lepu Biotechnology Completes Enrollment for Phase IIb Trial of MRG003 in Nasopharyngeal Carcinoma

February 11, 2025
CompanyMedical Device

Sino Medical Secures Approvals for Key Coronary Devices in Taiwan, India, and Uzbekistan

October 29, 2024
CompanyDrug

Shanghai Henlius Secures Indonesian Approval for HanSiZhuang in Small-Cell Lung Cancer

October 29, 2024
CompanyDeals

IVD Medical Ends Strategic Partnership with Japan’s Sysmex in Coagulation Products

October 29, 2024
CompanyDrug

Clover Biopharma’s SCB-219M Shows Promising Phase I Results for Chemotherapy-Induced Thrombocytopenia

October 29, 2024
CompanyDeals

Eli Lilly Completes Acquisition of Point Biopharma, Expanding Radiopharmaceutical Portfolio

October 29, 2024
CompanyDrug

Fosun’s HLX42 Receives Fast-Track Designation from FDA for NSCLC Treatment

October 29, 2024
1 2 3 … 21 22
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up